177 related articles for article (PubMed ID: 1827847)
1. Treatment of rat prostatic adenocarcinoma with medroxyprogesterone acetate (MPA): effects on growth and morphology.
Damber JE; Bergh A; Landström M; Tomić R
J Urol; 1991 Jun; 145(6):1283-7. PubMed ID: 1827847
[TBL] [Abstract][Full Text] [Related]
2. Effect of medroxyprogesterone acetate, alone or in combination with epirubicin hydrochloride, on the growth of the Dunning R3327H prostatic adenocarcinoma.
Landström M; Tomić R; Damber JE
Eur Urol; 1987; 13(3):203-6. PubMed ID: 2956111
[TBL] [Abstract][Full Text] [Related]
3. Antiestrogens do not counteract the inhibitory effect of estradiol-17 beta on the growth of the Dunning R3327 prostatic adenocarcinoma.
Landström M; Damber JE; Bergh A; Tomic R; Carlsson-Bostedt L; Stigbrand T
Prostate; 1988; 12(4):287-98. PubMed ID: 3393491
[TBL] [Abstract][Full Text] [Related]
4. Endocrinological effects of treatment with high doses of medroxyprogesterone acetate in patients with renal or prostatic adenocarcinoma.
Tomic R; Ljungberg B; Damber JE
Scand J Urol Nephrol Suppl; 1988; 110():185-7. PubMed ID: 2973122
[No Abstract] [Full Text] [Related]
5. Direct effects of oestradiol on growth and morphology of the Dunning R3327H prostatic carcinoma.
Daehlin L; Bergh A; Damber JE
Urol Res; 1987; 15(3):169-72. PubMed ID: 3629752
[TBL] [Abstract][Full Text] [Related]
6. Combined and sequential treatment using FCE 21336, a new prolactin-lowering drug, and medroxyprogesterone acetate (MPA) in DMBA-induced tumors in rats.
Zaccheo T; Casazza AM; di Salle E; Pollini C; di Marco A
Eur J Cancer Clin Oncol; 1984 Sep; 20(9):1193-7. PubMed ID: 6236980
[TBL] [Abstract][Full Text] [Related]
7. [High-dosage medroxyprogesterone acetate treatment in advanced prostatic cancer].
Flamm J; Spona J
Wien Klin Wochenschr; 1987 Oct; 99(19):682-6. PubMed ID: 2961131
[TBL] [Abstract][Full Text] [Related]
8. Estrogen treatment combined with castration inhibits tumor growth more effectively than castration alone in the Dunning R3327 rat prostatic adenocarcinoma.
Landström M; Bergh A; Tomic R; Damber JE
Prostate; 1990; 17(1):57-68. PubMed ID: 1696714
[TBL] [Abstract][Full Text] [Related]
9. Effect of medroxyprogesterone acetate and doxorubicin on sublines of 13762 mammary adenocarcinoma in rats.
Formelli F; Zaccheo T; Casazza AM; Bellini O; Di Marco A
Eur J Cancer Clin Oncol; 1981 Nov; 17(11):1211-21. PubMed ID: 6460631
[No Abstract] [Full Text] [Related]
10. Hormonal effects of high dose medroxyprogesterone acetate treatment in males with renal or prostatic adenocarcinoma.
Tomić R; Ljungberg B; Damber JE
Scand J Urol Nephrol; 1988; 22(1):15-8. PubMed ID: 2968646
[TBL] [Abstract][Full Text] [Related]
11. Effects of high dose medroxyprogesterone acetate treatment on antithrombin III and other plasma proteins in males with renal cell or prostatic carcinoma.
Nilsson TK; Tomic R; Ljungberg B
Scand J Urol Nephrol; 1989; 23(1):11-4. PubMed ID: 2522237
[TBL] [Abstract][Full Text] [Related]
12. Estrogen treatment of Dunning tumors in castrated rats: qualitative and quantitative morphology.
Landström M; Bergh A; Thornell LE; Virtanen I; Damber JE
Prostate; 1992; 20(3):199-211. PubMed ID: 1574467
[TBL] [Abstract][Full Text] [Related]
13. Effect of medroxyprogesterone acetate on the growth of mouse transplanted tumors: relation with hormone sensitivity.
Formelli F; Ronchi E; Di Fronzo G
Anticancer Res; 1985; 5(3):313-9. PubMed ID: 3160299
[TBL] [Abstract][Full Text] [Related]
14. Effects of tamoxifen, estradiol benzoate and medroxyprogesterone acetate on the growth of DMBA-induced rat mammary carcinoma.
Zanardi S; De Menech R; Pino G; Guarneri D; Dandolo G; Sanguineti M; Moro MG; Barbi GP; Paganuzzi M; Boccardo F
Chemioterapia; 1985 Jun; 4(3):239-42. PubMed ID: 3161642
[TBL] [Abstract][Full Text] [Related]
15. Effects of 17 beta-estradiol and medroxyprogesterone acetate upon MtTW15 mammosomatotropic pituitary tumor growth and hormone production in male and female rats.
Winneker RC; Parsons JA
Cancer Res; 1981 May; 41(5):1772-7. PubMed ID: 7214344
[TBL] [Abstract][Full Text] [Related]
16. [Combination effect of flutamide and leuprorelin acetate on growth of Dunning R3327-H prostatic adenocarcinoma in rats].
Tomura A; Kuroiwa S; Okada M; Abe F
Gan To Kagaku Ryoho; 1998 Mar; 25(4):563-9. PubMed ID: 9530363
[TBL] [Abstract][Full Text] [Related]
17. Blood flow in the Dunning R3327H rat prostatic adenocarcinoma; effects of oestradiol and testosterone.
Daehlin L; Damber JE
Urol Res; 1986; 14(2):113-7. PubMed ID: 3727214
[TBL] [Abstract][Full Text] [Related]
18. [Pain relief by high-dose medroxyprogesterone acetate in advanced prostatic cancer].
Sasagawa I; Satomi S; Umeda K; Katayama T
Hinyokika Kiyo; 1989 Apr; 35(4):603-8. PubMed ID: 2525316
[TBL] [Abstract][Full Text] [Related]
19. Estrogen treatment postpones the castration-induced dedifferentiation of Dunning R3327-PAP prostatic adenocarcinoma.
Landström M; Damber JE; Bergh A
Prostate; 1994 Jul; 25(1):10-8. PubMed ID: 8022707
[TBL] [Abstract][Full Text] [Related]
20. Additive inhibitory effects of bromocryptine (CB-154) and medroxyprogesterone acetate (MPA) on dimethylbenz[a]anthracene (DMBA)-induced mammary tumors in the rat.
Dauvois S; Spinola PG; Labrie F
Eur J Cancer Clin Oncol; 1989 May; 25(5):891-7. PubMed ID: 2525471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
